Pharmacotherapeutic Benefits NBof GIP Receptor Antagonism in Weight Management
- GIPR antagonism sensitizes GLP-1 receptor agonists and amylin agonists to deliver more profound weight loss especially in clinical conditions with increased insulin resistance
- GIPR antagonism improves cardiovascular risk and shows promise of delivering healthy weight loss